30 December 2025 in Dentistry: Theory and Practice
Gingival recession is a common clinical condition that leads to aesthetic dissatisfaction and dental hypersensitivity. Traditional surgical methods for soft tissue augmentation, while effective, are often invasive and require harvesting autogenous grafts. The search for minimally invasive alternatives has led to growing interest in injectable collagen-based biomaterials. Aim — to evaluate the clinical efficacy and safety of a xenogeneic collagen gel, “Collost,” for increasing soft tissue volume in the treatment of multiple gingival recessions. A 42-year-old female patient with multiple gingival recessions in the maxillary anterior region was treated. After initial professional hygiene, a 7% bovine collagen gel was injected into the soft tissues adjacent to the recessions according to a precise protocol, involving multiple injection points per tooth. A second injection was performed after 1 month to consolidate the result. Clinical outcomes were assessed immediately, at 2 weeks, and over a 12-month follow-up period. The procedure resulted in a significant increase in soft tissue volume and the elimination of gingival recessions, with a stable aesthetic outcome observed throughout the 12-month follow-up period. No adverse events, such as allergic reactions, inflammation, or material rejection, were reported. The protocol demonstrated good patient tolerance and a high safety profile. The use of xenogeneic collagen gel “Collost” is an effective and safe minimally invasive method for soft tissue augmentation in the treatment of gingival recessions. It provides a stable long-term result and represents a promising alternative to more invasive surgical techniques.